De Falco Nadia, Agresti Massimo, De Falco Massimo, Sperlongano Pasquale, Moccia Giancarlo, Luongo Pasquale, Cece Alessio, Bove Francesco, Miele Francesco, Allaria Alfredo, Torelli Francesco, Bassi Paola, Sciarra Antonella, Avenia Stefano, Della Monica Paola, Colapietra Federica, Di Domenico Marina, Docimo Ludovico, Parmeggiani Domenico
Department of Integrated Activities in Surgery, Orthopedy and Hepato-Gastroenterology, Univeristary Policlinico "Luigi Vanvitelli", 50134 Naples, Italy.
Department of Precision Medicine, University of Campania "Luigi Vanvitelli", 50134 Naples, Italy.
J Clin Med. 2025 Feb 19;14(4):1382. doi: 10.3390/jcm14041382.
While the frequency of papillary thyroid carcinoma (PTC) has increased in recent decades, both due to improvements in diagnostic procedures and a real, effective percentage increase in cases, the frequency of medullary thyroid carcinoma (MTC), however, has remained almost unchanged, representing 3-5% of thyroid cancer cases. Our experience relates to the observation of cases with the synchronous presence of PTC and MTC, also in chronic autoimmune thyroiditis, and this led us to carry out a brief review of the literature on the subject, with the aim above all of identifying the most correct postoperative therapeutic process.
近几十年来,甲状腺乳头状癌(PTC)的发病率有所上升,这既是由于诊断程序的改进,也是由于病例数量实际有效增加。然而,甲状腺髓样癌(MTC)的发病率几乎保持不变,占甲状腺癌病例的3%-5%。我们的经验涉及对PTC和MTC同时存在的病例的观察,包括慢性自身免疫性甲状腺炎中的病例,这促使我们对该主题的文献进行简要综述,主要目的是确定最正确的术后治疗过程。